Section 53.1 of the Patent Act took effect in 2019. It was designed to reverse the 2000 decision of the Supreme Court in Free World Trust v Electro Santé Inc [2000] 2 SCR 1024 and…
Category: Patentability
Blockchain on Every Street Corner – Walmart and the Rise of Mainstream Blockchain Patents
Walmart’s American patents and reported patent-related activities over the last few months show just how common blockchain-based technology is going to become in the immediate future. Walmart currently holds such patents…
The Highs and Lows of Patenting Marijuana Strains
After over 95 years of prohibition, recreational usage of marijuana will be legalized nation-wide on October 17th. While the Cannabis Act will transform cannabis breeding from an illegal cottage industry to a legitimate profession, there…
in Access to Medicines, Blogs, Commercialization, Development, Innovation, Patentability, Patents, Pharmaceutical Drugs, Uncategorized0by Editor
879
Broken Promises: Utility Standards and Patent Applications in Canada
The last day of June 2017 saw the Supreme Court of Canada (SCC) quash the controversial Promise Doctrine. The issue at hand in AstraZeneca Canada Inc v Apotex Inc was…
in Access to Medicines, Commercialization, Design, Development, IP, Patentability, Patents, Pharmaceutical Drugs, Uncategorized0by Editor
1329
What Makes It My Molecule: A Look at Professor Ronald Pearlman’s Genome Editing Work
This past November, Professor Ronald E. Pearlman from York University’s Department of Biology gave a talk [1] at Osgoode Hall Law School to discuss the potential of the innovative CRISPR…
Utility Emphasis Lacking in the Examination of Aggregations
The distinction between combinations and aggregations is a well-accepted principle of patent law. A combination is an assemblage of known elements whose combined use leads to a result that is…